WhitTier Trust Company’s Quest Diagnostics DGX Stock Holding History

WhitTier Trust Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	1,099 +53	+5%	+$10.4K	﹤0.01%	495
2026 Q1	$208K	Sell	1,046 -8	-0.8%	-$1.55K	﹤0.01%	492
2025 Q4	$190K	Sell	1,054 -5	-0.5%	-$910	﹤0.01%	489
2025 Q3	$190K	Hold	1,059	–	–	﹤0.01%	478
2025 Q2	$190K	Sell	1,059 -6	-0.6%	-$1.04K	﹤0.01%	530
2025 Q1	$180K	Buy	1,065 +28	+3%	+$4.6K	﹤0.01%	527
2024 Q4	$156K	Buy	1,037 +43	+4%	+$6.69K	﹤0.01%	538
2024 Q3	$154K	Sell	994 -15	-1%	-$2.24K	﹤0.01%	525
2024 Q2	$138K	Sell	1,009 -1	-0.1%	-$137	﹤0.01%	518
2024 Q1	$134K	Buy	1,010 +40	+4%	+$5.19K	﹤0.01%	526
2023 Q4	$134K	Buy	970 +33	+4%	+$4.34K	﹤0.01%	525
2023 Q3	$114K	Sell	937 -489	-34%	-$65.2K	﹤0.01%	528
2023 Q2	$200K	Buy	1,426 +21	+1%	+$2.9K	0.01%	466
2023 Q1	$199K	Hold	1,405	–	–	0.01%	463
2022 Q4	$220K	Hold	1,405	–	–	0.01%	453
2022 Q3	$172K	Hold	1,405	–	–	0.01%	485
2022 Q2	$186K	Hold	1,405	–	–	0.01%	471
2022 Q1	$192K	Hold	1,405	–	–	0.01%	468
2021 Q4	$244K	Hold	1,405	–	–	0.01%	439
2021 Q3	$205K	Buy	1,405 +447	+47%	+$65.4K	0.01%	455
2021 Q2	$126K	Buy	958 +455	+90%	+$59.6K	0.01%	505
2021 Q1	$64K	Hold	503	–	–	﹤0.01%	601
2020 Q4	$60K	Hold	503	–	–	﹤0.01%	591
2020 Q3	$57K	Hold	503	–	–	﹤0.01%	583
2020 Q2	$57K	Sell	503 -64	-11%	-$6.79K	﹤0.01%	557
2020 Q1	$45K	Hold	567	–	–	﹤0.01%	570
2019 Q4	$60K	Hold	567	–	–	﹤0.01%	565
2019 Q3	$61K	Hold	567	–	–	﹤0.01%	557
2019 Q2	$58K	Hold	567	–	–	﹤0.01%	562
2019 Q1	$51K	Hold	567	–	–	﹤0.01%	582
2018 Q4	$48K	Buy	567 +67	+13%	+$6.28K	﹤0.01%	576
2018 Q3	$54K	Hold	500	–	–	﹤0.01%	600
2018 Q2	$55K	Hold	500	–	–	﹤0.01%	590
2018 Q1	$50K	Hold	500	–	–	﹤0.01%	610
2017 Q4	$49K	Hold	500	–	–	﹤0.01%	577
2017 Q3	$47K	Hold	500	–	–	﹤0.01%	551
2017 Q2	$56K	Sell	500 -500	-50%	-$52.9K	0.01%	519
2017 Q1	$98K	Sell	1,000 -3,000	-75%	-$286K	0.01%	430
2016 Q4	$368K	Hold	4,000	–	–	0.04%	273
2016 Q3	$339K	Hold	4,000	–	–	0.04%	274
2016 Q2	$326K	Hold	4,000	–	–	0.04%	279
2016 Q1	$286K	Hold	4,000	–	–	0.03%	296
2015 Q4	$285K	Hold	4,000	–	–	0.03%	295
2015 Q3	$246K	Hold	4,000	–	–	0.03%	317
2015 Q2	$290K	Hold	4,000	–	–	0.03%	313
2015 Q1	$307K	Hold	4,000	–	–	0.03%	310
2014 Q4	$268K	Hold	4,000	–	–	0.03%	323
2014 Q3	$243K	Hold	4,000	–	–	0.03%	316
2014 Q2	$235K	Hold	4,000	–	–	0.03%	320
2014 Q1	$232K	Hold	4,000	–	–	0.03%	324
2013 Q4	$214K	Hold	4,000	–	–	0.03%	329
2013 Q3	$247K	Hold	4,000	–	–	0.03%	289
2013 Q2	$243K	Buy	+4,000	New	+$238K	0.04%	280

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

WhitTier Trust Company's DGX Position: Q2 2026 in Review

WhitTier Trust Company increased its Quest Diagnostics (DGX) stake by 5.1% in Q2 2026, buying an estimated $10.4K and bringing the position to 1,099 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

WhitTier Trust Company first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $368K in Q4 2016. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

WhitTier Trust Company held 1,099 shares of Quest Diagnostics worth $233K as of Q2 2026.
WhitTier Trust Company bought 53 Quest Diagnostics shares in Q2 2026, an estimated $10.4K.
Quest Diagnostics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #495 holding.
WhitTier Trust Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
WhitTier Trust Company's Quest Diagnostics position peaked at $368K in Q4 2016.
444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.